IsomAb appoints Dr Philip Brainin as Chief Executive Officer Posted on March 18, 2026March 18, 2026 by edgover
IsomAb makes two key appointments; Dr Shi Yin Foo as Non-Executive Director and Dr Gary Burgess as CMO Posted on February 25, 2025March 17, 2025 by isomabmin
IsomAb Announces Strategic Collaboration with Catalent Posted on October 29, 2024November 4, 2024 by pconington
IsomAb Appoints Dr Anker Lundemose as a Non-Executive Director Posted on April 16, 2024November 1, 2024 by edgover
IsomAb Announces Close of £7.5 Million Financing to Accelerate Lead Candidate Posted on February 20, 2024March 17, 2026 by edgover
